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Thereareanumberofdiﬀerentexperimentalmethodsforexvivoassessmentofblood-brainbarrier(BBB)openingbasedonEvans
blue dye extravasation. However, these methods require many diﬀerent steps to prepare the brain and need special equipment for
quantiﬁcation. We here report a novel, simple, and fast semiquantitative algorithm to assess BBB integrity ex vivo.T h em e t h o d
is particularly suitable for cranial window experiments, since it keeps the spatial information about where the BBB opened. We
validated the algorithm using sham controls and the established model of brain topical application of the bile salt dehydrocholate
for early BBB disruption. We then studied spreading depolarizations in the presence and the absence of the vasoconstrictor
endothelin-1 and found no evidence of early BBB opening (three-hour time window). The algorithm can be used, for example, to
assess BBB permeability ex vivo in combination with dynamic in vivo studies of BBB opening.
1.Introduction
Blood-brain barrier (BBB) disruption has been investigated
in a multitude of experimental studies on cerebral patholo-
gies. These include ischemic stroke, epilepsy, spreading
depolarizations (SD) in otherwise healthy na¨ ıve tissue [1–
4], or eﬀects of detergents such as bile salts [5]. However,
the knowledge on the early time course of BBB disruption
is limited in these conditions. It is of particular interest for
future clinical prevention and treatment of brain disorders
associated with BBB impairment to characterize the early
phase of BBB opening for the following reasons.
(i) From that moment on, damage of brain tissue can
aggravate due to blood components that can now enter the
brain without restriction.
(ii) Secondary eﬀects associated with BBB opening
such as edema and cerebral hemorrhage may limit the
application of early therapies to a certain time window.
This, for example, seems to apply to systemic thrombolysis
with recombinant tissue plasminogen activator (rt-PA) in
ischemic stroke which is limited to the 4.5-hour time
window.
(iii) The onset of disruption marks the time point when
drugs that are normally kept from entering the brain become2 Cardiovascular Psychiatry and Neurology
able to cross the barrier. This may be relevant for neuropro-
tective treatment that has been shown to be most eﬀective
when given either before or early after an initial insult. If a
given neuroprotectant does not normally pass through the
barrier but only crosses the barrier after disruption, it is
important to determine whether BBB opening occurs early
enough for the neuroprotectant to have a suﬃcient eﬀect on
its target in the parenchyma yet.
Even less is known about early BBB opening in gradually
developing focal ischemia since most animal models of
focal ischemia are designed to replicate severe sudden onset
ischemic events in humans occurring after embolic or
thrombotic occlusion of a large vessel. Gradually developing
focal ischemia, however, is of similar importance for human
stroke. It may, for example, occur in patients with delayed
cerebral ischemia after aneurismal subarachnoid hemor-
rhage or in vasculitides, and so forth.
Here, we compared early BBB opening in rats at three
hours in (i) the brain topical endothelin-1 (ET-1) model
of focal cerebral ischemia, (ii) SDs propagating through
healthy na¨ ıve cortex, (iii) the topical bile salt dehydrocholate
(DHC) model, and (iv) a sham control. For this purpose
we developed a simple, semiquantitative algorithm to assess
BBB disruption using the target to background ratio. We
chose the brain topical ET-1 model, since it allowed us to
induce a gradually developing focal ischemia by titrating
the constrictive eﬀect of diﬀerent concentrations of ET-1 on
the cerebral vasculature. This results in features such as the
absence of a terminal SD, clearly diﬀerent to the classical and
widelydistributedmodelofmiddlecerebralarteryocclusion.
Instead, the brain topical ET-1 model is characterized by
clustersofrecurrent,prolongedSDsthatrideonanultraslow
negative potential shift and lead to a persistent depression of
brainelectricalactivity[6,7].Despitetheabsenceofterminal
SD, histological assessment indicated previously neuronal
death in the cortex exposed to ET-1 [8]. Interestingly, we did
not ﬁnd evidence of early BBB disruption in cortex exposed
to ET-1 in the present study in contrast to cortex exposed to
DHC that served as a positive control.
2.MaterialsandMethods
2.1.Animals. MaleWistarrats(n=28;250–350g)wereanae-
sthetised with 100mg/kg body weight thiopental-sodium
(Trapanal,BYKPharmaceuticals,Konstanz,Germany)intra-
peritoneally,tracheotomised,andartiﬁciallyventilated(Eﬀe-
nberger Rodent Respirator, Eﬀenberger Med.-Techn. Ger¨ a-
tebau, Pfaﬃng/Attel, Germany).
After cannulation of the left femoral artery and vein
both vessels were continuously infused with saline solution
at 1mL/h. Body temperature was maintained at 38.0 ± 0.5◦C
using a heating pad. At all times during the experiments,
mean arterial pressure (MAP; RFT Biomonitor, Zw¨ onitz,
Germany) and end-expiratory partial pressure of carbon
dioxide (Heyer CO2 Monitor EGM I, Bad Ems, Germany)
were monitored, whereas arterial partial pressure of oxygen
(paO2), carbon dioxide (paCO2), and pH were measured
serially using a Compact 1 blood gas analyser (AVL Me-
dizintechnik GmbH, Bad Homburg, Germany).
An open cranial window was implanted as reported
previously [9–11]. First, a parietal craniotomy of 7 ×
4mm was performed using a saline-cooled drill. Then,
wax and dental cement (Paladur) were used to build the
outer rim of the cranial window. After removal of the dura
mater, an inﬂow tube was inserted in the wax rim to later
superfuse the brain cortex with artiﬁcial cerebrospinal ﬂuid
(aCSF). ACSF containing (mmol/L) K+ 3, Na+ 152, Ca2+
1.5, Mg2+ 1.2, HCO3
− 24.5, Cl− 135, glucose 3.7, and urea
6.7 was equilibrated with a special gas mixture in order to
yield physiological pH and partial gas pressures. A second
small drill hole in the temporal bone served to later elicit
SD by subdural application of potassium chloride (KCl,
150mmol/L).
Twoglassmicroelectrodeswerepositionedatthewindow
site in a cortical depth of 300µm below surface to record the
intracortical electrocorticogram (ECoG). Alternate current
(AC)-ECoG (bandpass: 0.5–45Hz) and direct current (DC)-
ECoG of each electrode were obtained using a diﬀerential
ampliﬁer (Jens Meyer, Munich, Germany).
2.2. Experimental Protocols. After surgery, the recording was
started, and the cranial window was ﬁrst superfused with
aCSF for one to one and a half hours to obtain baseline
parameters. In all four groups, 1mL of 2% Evans blue was
then slowly administered intravenously for ﬁve minutes.
Shortly thereafter, DHC (2mmol/L in aCSF) was applied
brain topically in the DHC group (group 1, n = 8), while
in the sham-operated control group (group 2, n = 6),
physiological aCSF was applied continuously for the whole
period of measurement. In animals of the ET-1 (Sigma-
Aldrich inc., Steinheim, Germany) group (group 3, n = 7),
ET-1 was administered brain topically in stepwise increases
from 10−8 to 10−7 to 10−6 mmol/L at one-hour intervals as
described previously [11]. In group 4 (n = 5), physiological
aCSF was applied brain topically in the recording window,
while SDs were induced manually with a droplet of KCl in
a remote window at three diﬀerent time points. From the
remote window, the SDs propagated to the na¨ ıve recording
window equipped with the microelectrodes.
Three hours after the potentially BBB compromising
events and approximately seven hours after the start of the
head surgery (Figure 1) ,r a t so fa l lg r o u p sw e r es a c r i ﬁ c e d
by decapitation. Brains were then extracted, rinsed carefully
withsalinesolution,andpreservedincold4%paraformalde-
hyde (PFA) solution for at least 48 hours. Each brain was
later cut into ﬁve coronal slices of 2mm thickness at and
around the window area. Pictures of all slices were taken
at 96 dots per inch (dpi) resolution (1040 × 1392 pixel)
as 48-bit RGB images (16bits per channel) using a digital
microscope camera (magniﬁcation ×10) (Leica DFC300 FX
Digital Color Camera, Leica Microsystems AG, CH-9435,
Heerbrugg, Switzerland).
2.3. Image Processing. In brief, brain slice images were
imported as Matlab variables: three-dimensional matrices
with the third dimension containing the three color com-
ponents of the RGB color model, while the other two
dimensions represent width and length of the image. In theCardiovascular Psychiatry and Neurology 3
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Figure 1: Experimental protocols. For a better overview, the important time points of the experimental protocols are visualized here. The
black time line shows the recording period starting at the end of surgery. The brown time line shows the overall experimental time starting
from anesthesia until death of the animals. BGA = blood gas analysis.
algorithm, the blue channel is selected from the RGB image
which renders the variables two-dimensional for further
calculations. Both, the three- and two-dimensional variables
are stored in the unsigned integer 16bit (uint16) format.
The minimum intensity of each image was arbitrarily set
to zero and the maximum intensity to 216, the maximum
value of the uint16 format. The term ﬁlter used in the
algorithm does not refer to technical but image ﬁlters.
Those are selecting mechanisms depending on intensities
and gradients (ﬁrst derivatives of intensities) or using the
“canny method” for edge detection succeeded by contour
interpolation. Thresholds for the image ﬁlters were adjusted
manually depending on the image quality. The ﬁlters were
used to distinguish brain from background of the image.
Pixel values were set to “one” when representing brain and
to “zero” when representing background. The information
of the thus-generated binary mask stores the location of
the brain. This spatial information can easily be accessed
later by matrix multiplication. The target to background
ratio (TBR) was calculated by dividing the median intensity
of the window area (target) by the corresponding value of
the contralateral hemisphere (background). Both intensity
values were normalized to an ipsilateral remote area. The
algorithm is further explained in Section 3.
2.4. Data Analysis. Data were analyzed by comparing
absolute changes of the DC-ECoG potential and relative
changes in Evans blue dye extravasation. Statistical tests are
mentioned more speciﬁcally in the results section. A P-value
of < .05 was considered statistically signiﬁcant. Data in text
and ﬁgures are given as median value as well as ﬁrst and third
quartiles in parentheses.
3. Results
3.1.EvaluationMethodofEvansBlueDyeExtravasation. BBB
disruption was assessed by calculating the TBR of relative
Evans blue dye extravasation in the cranial window region
compared to the corresponding region of the contralateral
hemisphere.
The digital images of all slices (ﬁve per brain) were
imported into Matlab variables and screened manually for
one representative slice of each rat brain that contained the
region of the cranial window. The chosen slices were then
further processed using the custom-made Matlab routine as
described (see also Figure 2 for the algorithm used). The
location of the brain was identiﬁed within the picture by
ﬁlters and displayed through a binary mask. The image
was then cropped (cutout image) down to the outermost
“brain pixel” identiﬁed by the ﬁlter process. The upper 20%
(value chosen manually) of the cutout brain image were
deﬁned as the region of interest (ROI) that approximately
represented the area between the upper cortical surface and
the ventricles. The routine provided a 50 × 50 pixel square
(∼0.3mm2,b l u es q u a r ei nFigure 3(c)) within the ROI of the
ipsilateral hemisphere(hemispherewith thecranial window)
and a corresponding equally sized square (white square in
Figure 3(c)) within the ROI of the contralateral hemisphere.4 Cardiovascular Psychiatry and Neurology
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Figure 2: Algorithm.
Furthermore, the algorithm delivered two corresponding
equally sized squares in the bottom region of the image (one
bottom square in each hemisphere), clearly outside the ROI
that were used to normalize the median intensities to yield a
relative value for each side. The size of the four squares (50
by50 pixels) waschosen accordingto the widthof the cranial
window (∼4mm) and thickness of the rat cortex. The initial
location of the ﬁrst square was user-selected according to the
center of the cranial window area. This position was stored
using distance values from the edges of the mask.
Since RGB is an additive color model, the blue channel
of the images represents best the amount of blue dye
(Evans blue). Therefore, the relative median blue intensities
of both, the ipsilateral (blue square in the upper right
hemisphere of Figure 3(c) = target) and the contralateralside
(corresponding white square in the upper left hemisphere of
Figure 3(c) = background) were used to calculate the TBR.
As a visual control the routine plotted all four squares (blue
and white ones) found in the image (Figure 3(c)).
3.2. DHC Induced Early BBB Opening Was Detected by the
Novel Algorithm. The systemic variables measured in this
study were mean arterial pressure, arterial pCO2,a r t e r i a l
pO2, and pH. Mean arterial pressure above 75mmHg, arte-
rial pO2 between 90 and 130mmHg, arterial pCO2 between
35 and 45mmHg, and arterial pH between 7.35 and 7.45
wereacceptedasbeingphysiological[8].Thosesystemicvari-
ables remained within normal limits throughout the prepa-
ration and experiments in the four experimental groups.
We ﬁrst evaluated the brains of eight DHC-treated
(group 1) and six sham-operated rats (group 2), since it
was shown previously that topical application of DHC is
a robust method for early BBB disruption [5]. These two
groups served as positive and negative controls for BBB
opening, respectively, in order to determine whether our fast
algorithm would be able to detect the leakage of Evans blue
into the brain tissue.
Brain topical application of DHC led to a signiﬁcant
increase in Evans blue extravasations compared to the shamCardiovascular Psychiatry and Neurology 5
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Figure 3: Steps of the algorithm. This ﬁgure shows how an original picture, taken by a digital camera, is processed using the Matlab routine.
(a) First, the brain was identiﬁed within the picture, and a mask was created to reduce the background noise. (b) Then, the blue layer of
the picture was analyzed, and the intensity scale was adjusted. (c) The four squares were chosen, and the target to background ratio was
calculated.
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Figure 4: BBB opening. DHC-treated cortex shows signiﬁcant (∗)
Evans blue leakage in contrast to the three other groups (Kruskal-
WallisANOVAonrankstestwithDunn’sposthocanalysis,P<. 05).
operated group (Kruskal-Wallis ANOVA on ranks test with
Dunn’s post hoc analysis, P<. 05, Figure 4). DHC did not
induce SDs. Neither brain topical application of ET-1 (group
3, n = 7) nor SDs propagating through the na¨ ıve window
area (group 4, n = 5) led to any changes in Evans blue
extravasations compared to the sham-operated animals at
this early time point (Figure 4).
In group 3, topical application of ET-1 induced 4 (2–6)
S D sw i t ha na m p l i t u d eo f−13.6 (−18.2–(−11.9))mV and a
duration of 104 (71–215) s, while, in group 4, 7 (7–9) SDs
occurred with an amplitude of −13.7 (−16.8–(−9.2)) mV
and a duration of 46 (35–50)s. The duration of SDs was
signiﬁcantly longer in presence of ET-1 (P = .018, Mann-
Whitney rank sum test) [6]( Figure 5).
4. Discussion
We developed a novel, simple, and fast algorithm to assess
BBB disruption ex vivo. Using this algorithm, we conﬁrmed
5
m
V
(a)
5
m
V
10min
(b)
Figure 5: SDs in presence and absence of ET-1. (a) shows a typical
SD in the cortex exposed to ET-1, while (b) demonstrates a typical
SD in na¨ ıve cortex. Note the diﬀerence in duration and shape of
the SDs. It has been suggested that ET-1 induces conditions of an
ischemic penumbra. In the ischemic penumbra, SDs are typically
prolonged.
previousﬁndingsthatbraintopicalapplicationofthebilesalt
DHC causes early BBB opening. Neither ET-1-induced SDs
norSDspropagatinginna¨ ıvecortexledtoearlyBBBopening
within the three-hour time window.
OurexvivoalgorithmisbasedonEvansbluedyeextrava-
sations. Evans blue, discovered in 1885 by Paul Ehrlich [12],
binds to albumin with high aﬃnity. This large complex of
serum protein and vital dye cannot cross the intact BBB.
Methods already exist to assess ex vivo Evans blue leakage6 Cardiovascular Psychiatry and Neurology
from the cerebral vasculature into the brain tissue. However,
these methods include several time-consuming steps to
prepare the animal brain, and they also require special
equipment for quantiﬁcation. Therefore, they are more
costly and time-consuming. This applies to the commonly
used method of Katayama and colleagues [13], for example,
which is outlined brieﬂy in [4]. At ﬁrst, Evans blue is injected
intravenously in a 2% solution in saline (3mL/kg body
weight) either before or shortly after an insult. Perfusion
with physiological saline of the deeply anesthetized animal
is necessary to remove the dye inside the vessels at the end of
the experiment. After sacriﬁcing the animal and extraction
of the brain, either whole hemispheres or brain samples
from each side are chosen, weighed, and soaked overnight
in potassium hydroxide at 37◦C. The alkaline solution is
then neutralized by adding phosphoric acid and acetone
and shaken vigorously. Thereafter, the solution is centrifuged
threetimesat3500rpmfor15minutesandtheabsorbanceof
the extracted solution is measured using a spectrophotome-
ter. Quantitative calculation of the dye content in the brain is
then performed based on external standards.
In our current study, we aimed at an easier, less time-
and resources-consuming, semiquantitative ex vivo BBB
evaluatingmethod,sinceourexperimentalparadigmdidnot
require absolute quantiﬁcation. Our results show that this
fast and inexpensive new algorithm is speciﬁc enough to
identify early BBB disruption, veriﬁed by the DHC-model
[5]. It is, however, not absolutely quantitative but only
suitable for relative measurements. Therefore, we suggest
its use once there is need of evidence for whether BBB
openedornotinagivenregioncomparedtothecontralateral
hemisphere.Foranabsolutequantiﬁcation,weareinfavorof
the method described by Katayama and colleagues [13]. On
the other hand, a clear advantage of our method over that
of Katayama and colleagues is that the spatial information
is better preserved where exactly in the tissue the BBB dis-
ruption did occur. Thus, our method is suitable in particular
for the ex vivo assessment of BBB opening in cranial window
experiments in comparison to sham controls.
In vivo technology for the detection of BBB opening
provides the advantage that dynamics of BBB opening can
be studied. For this purpose, MR imaging is suitable as well
as CT technology [14, 15]. Moreover, PET solutions have
been discussed. For the speciﬁc purpose of cranial window
experiments, an elegant method for the evaluation of BBB
opening in vivo is ﬂuorescent imaging of molecules with
diﬀerent molecular weights such as Lucifer Yellow using a
CCD camera [16]. This method combines a high spatial
with a high temporal resolution. Our algorithm can be used
as a simple procedure to conﬁrm the in vivo ﬁndings with
another method ex vivo.
4.1. ET-1-Induced SDs as well as SDs Propagating in Na¨ ıve
TissueDoNotLeadtoSigniﬁcantEarlyBBBOpening.In1993,
Stanimirovic and colleagues reported that ET-1 increased
cerebrovascular endothelium permeability in cultures deri-
ved from human brain capillary endothelial cells [17].
They suggested that this eﬀect of ET-1 is due to receptor-
speciﬁc activation of protein kinase C and intracellular
calcium mobilization. Narushima and colleagues conse-
quently showed in dogs that a single dose (40pmol/animal)
of ET-1 administered intracisternally led to enhanced ﬂuo-
resceinentryintothecerebrospinalﬂuid[18].Thiseﬀectwas
reversible by preadministration of the selective endothelin
type A receptor (ETA) antagonist S-0139. Matsuo and
colleagues showed that S-0139 administration decreased
brain edema and albumin extravasation in a rat ischemia
model, where the ischemia was not induced by ET-1 but due
to middle cerebral artery ﬁlament occlusion [19]. This study
suggested that ET-1 is released in the wake of focal ischemia
in general and is involved via ETA receptors in the delayed
BBB disruption following focal ischemia. Cerebral ischemia
and reperfusion injury seem to induce dynamic changes in
the BBB permeability [20, 21]. Initial very slight changes are
assumed to be reversible and less harmful. After a refractory
period of more than three and less than ﬁve hours, a more
marked and persistent BBB disruption develops which may
interfere with therapies such as thrombolysis, shows side
eﬀects such as vasogenic edema, and is thus a target for
therapeutic intervention [20, 21].
Our data suggest that there is no signiﬁcant BBB
disruption in the ﬁrst few hours after topical administration
of ET-1. The prolongation of SDs under ET-1 in contrast to
SDs in na¨ ıve tissue indicated that the vasoconstrictor ET-1
produced conditions of an ischemic penumbra consistently
with previous ﬁndings [6, 8]. Hence, it is very likely that we
couldhavedetectedBBBdisruptionatatimepointlaterthan
three hours, since focal ischemia is associated typically with
BBB disruption in a delayed fashion after the third hour [22–
24]. Thus, the lack of early BBB disruption in response to
ET-1 provides in fact an argument that the BBB disruption
induced by ET-1 in previous studies in vivo may have been
secondary to ET-1-induced vasoconstriction and ischemia
rather than due to a direct eﬀect of ET-1 on the barrier.
However, we cannot exclude that very subtle permeability
changes escaped our BBB evaluating algorithm or that an
increase in permeability occurs for smaller molecules than
the albumin-Evans-blue complex.
We neither found an early BBB opening after SDs
propagating in na¨ ıve healthy tissue. This seems to contradict
previous data in which matrix metalloproteinase (MMP)-9
was demonstrated to contribute to BBB permeability, edema
formation, and vascular leakage after mechanically induced
SDs in rats [4]. According to that study, MMP-9 activation
occurred within the matrix of cortical blood vessels as early
as 15 to 30 minutes and started within neurons more than
three hours after SD induction. The authors reported an
early BBB opening at three hours after SD induction, where
BBBpermeabilitywasevaluatedbyquantiﬁcationofvascular
leakage of Evans blue dye using the method of Katayama
and colleagues [13]. It is possible that our algorithm was not
sensitiveenoughtodetectasubtleearlyBBBopening.Onthe
other hand, we used a less invasive method for SD induction
(droplets of KCl at 150mmol/L in a remote window) rather
than a mechanical injury by pin prick. This might have
inﬂuenced the time course of BBB opening.Cardiovascular Psychiatry and Neurology 7
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